Personal information

Verified email domains

nursing, cancer, health services, quality of care
United States

Biography

Elizabeth Tone Hosmer Professor, University of Michigan School of Nursing, Division of Systems, Populations, and Leadership

Activities

Employment (2)

University of Michigan School of Nursing: Ann Arbor, MI, US

2016-09-01 to present | Professor (Systems, Populations, and Leadership)
Employment
Source: Self-asserted source
Christopher Ryan Friese

University of Michigan School of Nursing: Ann Arbor, MI, US

2009-09-01 to 2016-08-31 | Assistant Professor (Department of Systems, Leadership, and Populations)
Employment
Source: Self-asserted source
Christopher Ryan Friese

Education and qualifications (4)

Harvard School of Public Health: Boston, MA, US

2008-06-30 | Post Doctoral Fellowship (Department of Social and Behavioral Sciences)
Education
Source: Self-asserted source
Christopher Ryan Friese

Dana Farber Cancer Institute: Boston, MA, US

2008-06-30 | Post Doctoral Fellow (Center for Outcomes and Policy Research )
Education
Source: Self-asserted source
Christopher Ryan Friese

University of Pennsylvania: Philadelphia, PA, US

2005-06-30 | PhD (School of Nursing)
Education
Source: Self-asserted source
Christopher Ryan Friese

University of Pennsylvania: Philadelphia, PA, US

1997-05 | BSN (School of Nursing)
Education
Source: Self-asserted source
Christopher Ryan Friese

Professional activities (9)

PCORI: Washington, DC, US

2019-09-01 to present | Board of Governors
Service
Source: Self-asserted source
Christopher Ryan Friese

National Cancer Institute: Md., Md., US

2021-09 to 2026-09 | National Cancer Advisory Board Member
Service
Source: Self-asserted source
Christopher Ryan Friese

Sigma Theta Tau International: IN, US

2022-08 | International Nurse Researcher Hall of Fame
Distinction
Source: Self-asserted source
Christopher Ryan Friese

National Academy of Medicine: Washington, DC, US

2020-10-19 | Elected Member
Distinction
Source: Self-asserted source
Christopher Ryan Friese

Oncology Nursing Society: PA, PA, US

2020-05 | Distinguished Researcher Award
Distinction
Source: Self-asserted source
Christopher Ryan Friese

National Academy of Medicine: Washington, DC, US

2017 to 2020 | Emerging Leader in Health and Medicine
Invited position
Source: Self-asserted source
Christopher Ryan Friese

University of Michigan: Ann Arbor, MI, US

2016 | Henry Russel Award for Junior Faculty
Distinction
Source: Self-asserted source
Christopher Ryan Friese

Oncology Nursing Society: Pittsburgh, PA, US

2015 | Rose Mary Carroll-Johnson Distinguished Award for Consistent Contributions to Nursing Literature, Oncology Nursing Society
Distinction
Source: Self-asserted source
Christopher Ryan Friese

American Academy of Nursing: Washington , DC, US

2012 | Fellow
Distinction
Source: Self-asserted source
Christopher Ryan Friese

Funding (14)

Making the right choice: Medicare plan selection and access to cancer care

2022-06 to 2024-05 | Grant
Leukemia and Lymphoma Society (White Plains, New York, US)
Source: Self-asserted source
Christopher Ryan Friese

Michigan Oncology Quality Consortium

2022-01 to 2022-12 | Contract
Blue Cross Blue Shield of Michigan (Detroit, US)
Source: Self-asserted source
Christopher Ryan Friese

Interdisciplinary Research Training Center in Cancer Care Delivery

2020-07-01 to 2025-06-30 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: T32CA236621
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

ACS Doctoral Scholarship in Cancer Nursing: Alex J Fauer

2019 to 2021 | Grant
American Cancer Society (GA, GA, US)
Source: Self-asserted source
Christopher Ryan Friese

Multi-Modal Interprofessional Training to Improve Chemotherapy Safety

2017-09-01 to 2022-08-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: R25CA214227
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

National Program Office: Alliance to Advance Patient-Centered Cancer Care

2017 to 2022 | Award
Merck Company Foundation (NJ, NJ, US)
Source: Self-asserted source
Christopher Ryan Friese

Communication Processes, Technology, and Patient Safety in Ambulatory Oncology Settings

Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

Robert Wood Johnson Foundation Health Policy Fellows -- Christopher Ryan Friese, PhD, RN, AOCN, MS, FAAN

2016-09-01 to 2018-08-31 | Grant
Robert Wood Johnson Foundation (Princeton, US)
GRANT_NUMBER: 73553
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

RANDOMIZED CONTROLLED TRIAL TO IMPROVE ONCOLOGY NURSES' PROTECTIVE EQUIPMENT USE

2014-07 to 2018-06 | Award
National Institute for Occupational Safety and Health (GA, GA, US)
GRANT_NUMBER:

R01OH01058

Source: Self-asserted source
Christopher Ryan Friese

INDIVIDUALIZATION OF SYSTEMIC THERAPY IN PATIENTS WITH ESTROGEN RECEPTOR-POS

2012-09 to 2016-08 | Award
National Cancer Institute (MD, MD, US)
GRANT_NUMBER:

P01CA163233

Source: Self-asserted source
Christopher Ryan Friese

Fostering Independence in Nursing and Outcomes Research

2010-07-02 to 2013-06-30 | Grant
National Institute of Nursing Research (Bethesda, US)
GRANT_NUMBER: 5R00NR010750-05
GRANT_NUMBER: 5R00NR010750-05
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

Fostering Independence in Nursing and Outcomes Research

2008-09-18 to 2010-06-30 | Grant
National Institute of Nursing Research (Bethesda, US)
GRANT_NUMBER: 5K99NR010750-02
GRANT_NUMBER: 5K99NR010750-02
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

Neutropenia Outcomes: Nurse Staffing and Environment Effects

2003-10-01 to 2005-12-01 | Grant
Oncology Nursing Society (Pittsburgh, US)
GRANT_NUMBER: ONS03MO01
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

Cancer Center Support Grant 2018-2023

1988-09-30 to 2023-05-31 | Grant
National Cancer Institute (Rockville, US)
GRANT_NUMBER: P30CA046592
Source: Self-asserted source
Christopher Ryan Friese via DimensionsWizard

Works (50 of 243)

Items per page:
Page 1 of 5

Estimating financial and health burden by initial Medicare plan choice and history of cancer

Health Affairs Scholar
2025-01-13 | Journal article
Contributors: Shelley A Jazowski; Emma M Achola; Lauren Hersch Nicholas; William A Wood; Christopher R Friese; Stacie B Dusetzina
Source: check_circle
Crossref

Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science Evolves

JCO Oncology Practice
2024-11 | Journal article
Contributors: Kathryn DeCarli; Angela Bradbury; Ana Maria Lopez; Polo Camacho; Monica S. Chatwal; Christopher R. Friese; Rachel Jimenez; Liza-Marie Johnson; Amy L. McGuire; Rebecca Spence et al.
Source: check_circle
Crossref

Reducing Information and Selection Bias in EHR-Linked Biobanks via Genetics-Informed Multiple Imputation and Sample Weighting

2024-10-29 | Preprint
Contributors: Maxwell Salvatore; Ritoban Kundu; Jiacong Du; Christopher R Friese; Alison M Mondul; David Hanauer; Haidong Lu; Celeste Leigh Pearce; Bhramar Mukherjee
Source: check_circle
Crossref

Data from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S10 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S10 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S3 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S3 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S4 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S4 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S5 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S5 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S6 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S6 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S7 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S7 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S8 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S8 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S9 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S9 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Materials and Methods from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Materials and Methods from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S3 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S3 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S4 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S4 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S5 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S5 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S6 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Table S6 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2024-05-17 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

The Acceptance and Use of Digital Technologies for Self-Reporting Medication Safety Events After Care Transitions to Home in Patients With Cancer: Survey Study

Journal of Medical Internet Research
2024-03-08 | Journal article
Contributors: Yun Jiang; Misun Hwang; Youmin Cho; Christopher R Friese; Sarah T Hawley; Milisa Manojlovich; John C Krauss; Yang Gong
Source: check_circle
Crossref

Nurses’ Perceptions of Licensure Compact Legislation to Facilitate Interstate Practice: Results From the 2022 Michigan Nurses’ Study

Policy, Politics, & Nursing Practice
2024-02 | Journal article
Contributors: Barbara R. Medvec; Marita G. Titler; Christopher R. Friese
Source: check_circle
Crossref

To weight or not to weight? Studying the effect of selection bias in three large EHR-linked biobanks

2024-02-13 | Preprint
Contributors: Maxwell Salvatore; Ritoban Kundu; Xu Shi; Christopher R Friese; Seunggeun Lee; Lars G Fritsche; Alison M Mondul; David Hanauer; Celeste Leigh Pearce; Bhramar Mukherjee
Source: check_circle
Crossref

Comparing Medicare plan selection among beneficiaries with and without a history of cancer

Health Affairs Scholar
2024-02-01 | Journal article
Contributors: Shelley A Jazowski; Emma M Achola; Lauren H Nicholas; William A Wood; Christopher R Friese; Stacie B Dusetzina
Source: check_circle
Crossref

Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications

Supportive Care in Cancer
2023-11 | Journal article
Contributors: Milisa Manojlovich; Amanda Blok; Nathan Wright; Emily Azhari; Karen B. Farris; Christopher R. Friese; Emily Mackler; Marita Titler; Mary Byrnes
Source: check_circle
Crossref

Data from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S1 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S10 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S10 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref

Supplementary Figure S2 from COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

2023-11-20 | Preprint
Contributors: Maxwell Salvatore; Miriam M. Hu; Lauren J. Beesley; Alison M. Mondul; Celeste Leigh Pearce; Christopher R. Friese; Lars G. Fritsche; Bhramar Mukherjee
Source: check_circle
Crossref
Items per page:
Page 1 of 5

Peer review (1 review for 1 publication/grant)

Review activity for Nursing outlook. (1)